Chow AT - Search Results

1

The utility of modeling and simulation approaches to evaluate immunogenicity effect on the therapeutic protein pharmacokinetics.

Perez Ruixo JJ, Ma P, Chow AT. Perez Ruixo JJ, et al. Among authors: chow at. AAPS J. 2013 Jan;15(1):172-82. doi: 10.1208/s12248-012-9424-8. Epub 2012 Nov 10. AAPS J. 2013. PMID: 23139019 Free PMC article. Review.

2

Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjects.

Wang YM, Krzyzanski W, Doshi S, Xiao JJ, Pérez-Ruixo JJ, Chow AT. Wang YM, et al. Among authors: chow at. AAPS J. 2010 Dec;12(4):729-40. doi: 10.1208/s12248-010-9234-9. Epub 2010 Oct 21. AAPS J. 2010. PMID: 20963535 Free PMC article.

3

Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis.

Sutjandra L, Rodriguez RD, Doshi S, Ma M, Peterson MC, Jang GR, Chow AT, Pérez-Ruixo JJ. Sutjandra L, et al. Among authors: chow at. Clin Pharmacokinet. 2011 Dec 1;50(12):793-807. doi: 10.2165/11594240-000000000-00000. Clin Pharmacokinet. 2011. PMID: 22087866

4

Exposure-response modeling of darbepoetin alfa in anemic patients with chronic kidney disease not receiving dialysis.

Doshi S, Chow A, Pérez Ruixo JJ. Doshi S, et al. J Clin Pharmacol. 2010 Sep;50(9 Suppl):75S-90S. doi: 10.1177/0091270010377201. J Clin Pharmacol. 2010. PMID: 20881221

5

Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Doshi S, Krzyzanski W, Yue S, Elliott S, Chow A, Pérez-Ruixo JJ. Doshi S, et al. Clin Pharmacokinet. 2013 Dec;52(12):1063-83. doi: 10.1007/s40262-013-0098-x. Clin Pharmacokinet. 2013. PMID: 23912564 Review.

6

Quantitative pharmacology of denosumab in patients with bone metastases from solid tumors.

Perez Ruixo JJ, Doshi S, Sohn W, Chow A. Perez Ruixo JJ, et al. J Clin Pharmacol. 2015 Mar;55 Suppl 3:S85-92. doi: 10.1002/jcph.388. J Clin Pharmacol. 2015. PMID: 25707967 Review.

7

Pharmacokinetic-pharmacodynamic modelling of neutrophil response to G-CSF in healthy subjects and patients with chemotherapy-induced neutropenia.

Melhem M, Delor I, Pérez-Ruixo JJ, Harrold J, Chow A, Wu L, Jacqmin P. Melhem M, et al. Br J Clin Pharmacol. 2018 May;84(5):911-925. doi: 10.1111/bcp.13504. Epub 2018 Feb 20. Br J Clin Pharmacol. 2018. PMID: 29318653 Free PMC article.

8

Prediction of Survival Benefit of Filgrastim in Adult and Pediatric Patients With Acute Radiation Syndrome.

Harrold J, Gisleskog PO, Perez-Ruixo JJ, Delor I, Chow A, Jacqmin P, Melhem M. Harrold J, et al. Clin Transl Sci. 2020 Jul;13(4):807-817. doi: 10.1111/cts.12777. Epub 2020 Apr 6. Clin Transl Sci. 2020. PMID: 32112517 Free PMC article.

9

Population pharmacokinetic analysis of panitumumab in patients with advanced solid tumors.

Ma P, Yang BB, Wang YM, Peterson M, Narayanan A, Sutjandra L, Rodriguez R, Chow A. Ma P, et al. J Clin Pharmacol. 2009 Oct;49(10):1142-56. doi: 10.1177/0091270009344989. Epub 2009 Sep 1. J Clin Pharmacol. 2009. PMID: 19723673

10

Denosumab dose selection for patients with bone metastases from solid tumors.

Doshi S, Sutjandra L, Zheng J, Sohn W, Peterson M, Jang G, Chow AT, Pérez-Ruixo JJ. Doshi S, et al. Among authors: chow at. Clin Cancer Res. 2012 May 1;18(9):2648-57. doi: 10.1158/1078-0432.CCR-11-2944. Epub 2012 Mar 6. Clin Cancer Res. 2012. PMID: 22394983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters